HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Gets Portfolio In Order While Riding Prestige Beauty, Functional Nutrition Growth

Executive Summary

Unilever’s prestige beauty business, bulked up by acquisitions over the past five years, achieved 21% underlying sales growth in the FY 2021 first quarter. The firm has formed a new business unit, Elida Beauty, to house a number of smaller, non-core beauty and personal-care brands accounting for around 600m in revenues following talk of possible divestitures.

You may also be interested in...



Unilever Targets Hair Health From Inside-Out With Nutrafol Acquisition

After five years with a minority interest in Nutrafol for “clinically proven hair growth,” Unilever will acquire a majority stake in the supplements brand under undisclosed terms. Nutrafol says its nutraceuticals for men and women – sold through multiple channels including by more than 3,000 physicians – target “the six root causes affecting hair health.”

Unilever Stepping Up Pricing To Offset Rising Costs While New Businesses Continue To Fuel Growth

“We are still managing in COVID times,” says CEO Alan Jope during Unilever’s 22 July call to discuss fiscal 2021 first-half results.

Unilever To Fuel Skin Care, E-Commerce Engines With Paula’s Choice Acquisition

Paula’s Choice ticks skin-care and e-commerce boxes at a time of increased wellness and home shopping demand. The balance it strikes between acknowledging consumer ingredient preferences and upholding scientific method may also be part of the brand's appeal.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151284

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel